Genomtec S.A. (WSE:GMT)

Genomtec Income Statement

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	0	0	0.04	0.22	0.02
Revenue Growth (YoY)	-94.74%	-97.50%	-81.73%	995.00%	-
Cost of Revenue	2.63	0.79	3.27	5.38	3.53
Gross Profit	-2.63	-0.79	-3.23	-5.16	-3.51
Selling, General & Admin	11.2	9.43	8.57	5.36	10.97
Other Operating Expenses	-2.55	-1.5	-0.31	-3.53	-3.62
Operating Expenses	8.65	7.93	8.26	1.83	7.36
Operating Income	-11.28	-8.73	-11.49	-7	-10.86
Interest Expense	-0.11	-0.12	-0.2	-0.03	-0.02
Interest & Investment Income	0.01	-	-	-	0
Currency Exchange Gain (Loss)	-0.07	-0.13	-0.1	-0.09	-0.06
Other Non Operating Income (Expenses)	0.06	-0.05	-0.09	-	-0
Pretax Income	-11.46	-9.03	-11.88	-7.11	-10.94
Income Tax Expense	0.12	-0.02	0.05	0.01	0
Net Income	-11.58	-9.01	-11.93	-7.12	-10.94
Net Income to Common	-11.58	-9.01	-11.93	-7.12	-10.94
Shares Outstanding (Basic)	13	12	9	8	8
Shares Outstanding (Diluted)	13	12	9	8	8
Shares Change (YoY)	18.87%	30.90%	14.78%	-	-
EPS (Basic)	-0.87	-0.74	-1.27	-0.87	-1.34
EPS (Diluted)	-0.87	-0.74	-1.27	-0.87	-1.34
Free Cash Flow	-9.74	-11.48	-7.93	-5.71	-2.63
Free Cash Flow Per Share	-0.73	-0.94	-0.85	-0.70	-0.32
Operating Margin	-1128300.00%	-872700.00%	-28730.00%	-3194.06%	-54315.00%
Profit Margin	-1157600.00%	-901300.00%	-29820.00%	-3248.86%	-54695.00%
Free Cash Flow Margin	-974300.00%	-1147900.00%	-19822.50%	-2608.68%	-13135.00%
EBITDA	-8.92	-7.57	-11.06	-6.49	-10.62
D&A For EBITDA	2.36	1.16	0.44	0.5	0.24
EBIT	-11.28	-8.73	-11.49	-7	-10.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.